U.S. Markets closed

Agile Therapeutics Gets a Path Forward for Twirla, Analysts Review and Target

NEW YORK, NY / ACCESSWIRE / October 22, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Agile Therapeutics, Inc. (AGRX), a women's healthcare company dedicated to fulfilling the unmet health needs of women. The company' product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.

The company' shares continue to gain after its recent announcements, and after it announced the completion of Formal Dispute Resolution Process with the FDA.

About AGRX and progress with the FDA, analysts review, and target in this full report READ MORE

Copy and paste to your browser may be required to view the report with no obligation - https://tradersnewssource.com/agile-therapeutics/

The company' lead product candidate, Twirla® (levonorgestrel/ethinyl estradiol transdermal system) or AG200-15, is an investigational low-dose, non-daily, prescription contraceptive. Twirla is based on the company' proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin.

In addition to Twirla, the company is also developing a pipeline of other new transdermal contraceptive products.

Review the entire AGRX pipeline, company highlights and financial data in the full report READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/agile-therapeutics/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source